Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 19:35:01 06/03/2026 +03			5-day change	1st Jan Change
2,038.00 ^GBX	-1.83%		-7.41%	+11.70%

03-05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
03-05	GSK outgoing CEO Emma Walmsley's 2025 total remuneration was 15.7 mln pounds vs 10.6 mln pounds in 2024 - annual report	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	80,458	58,381	59,112	54,944	73,201	83,213	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	13.68%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	95,195	92,466	90,485
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.6%	-2.87%	-2.14%
P/E ratio	18.6x	3.93x	11.9x	21.3x	12.9x	13x	12.1x	11.6x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.42x	3.69x	3.28x
PEG	-	0x	-0.2x	-0.4x	0x	1x	1.56x	2.74x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.46x	2.35x	2.28x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.82x	2.61x	2.48x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.15x	7.45x	7.15x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.35x	8.39x	7.78x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	14.9x	14.4x	12.6x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.7%	6.94%	7.92%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.693	0.761	0.7633
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.34%	3.67%	3.68%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.594	1.717	1.79
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	43.5%	44.3%	42.6%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,804	35,419	36,517
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,681	12,415	12,648
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,176	11,019	11,626
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,311	6,796	7,183
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	11,982	9,253	7,272
Reference price ²	20.08	14.38	14.50	13.46	18.24	20.76	20.76	20.76
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,008,335	-	-
Announcement Date	2/9/22 A	2/1/23 A	1/31/24 A	2/5/25 A	2/4/26 A	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GSK PLC	14.95x	2.99x	8.66x	3.12%	111B
ELI LILLY AND COMPANY	28.9x	10.89x	21.87x	0.67%	878B
JOHNSON & JOHNSON	24.39x	5.92x	16.12x	2.21%	577B
ABBVIE INC.	25.23x	6.89x	13.83x	2.98%	411B
ROCHE HOLDING AG	18.73x	4.61x	11.4x	2.86%	359B
ASTRAZENECA PLC	24.72x	5.15x	14.27x	1.69%	305B
NOVARTIS AG	21.6x	5.83x	14.37x	2.77%	304B
MERCK & CO., INC.	27.13x	4.76x	14.87x	2.91%	287B
AMGEN INC.	24.73x	6.28x	11.17x	2.73%	198B
GILEAD SCIENCES, INC.	20.12x	6.12x	11.07x	2.24%	180B
Average	23.05x	5.94x	13.76x	2.42%	361.02B
Weighted average by Cap.	24.55x	6.88x	15.63x	2.11%